Mobile health technology (mDiab) for the prevention of type 2 diabetes: protocol for a randomized controlled trial

Muralidharan, Shruti, Mohan, Viswanathan, Anjana, Ranjit Mohan, Jena, Sidhant, Tandon, Nikhil, Allender, Steven and Ranjani, Harish 2017, Mobile health technology (mDiab) for the prevention of type 2 diabetes: protocol for a randomized controlled trial, JMIR research protocols, vol. 6, no. 12, pp. 1-12, doi: 10.2196/resprot.8644.

Attached Files
Name Description MIMEType Size Downloads

Title Mobile health technology (mDiab) for the prevention of type 2 diabetes: protocol for a randomized controlled trial
Author(s) Muralidharan, ShrutiORCID iD for Muralidharan, Shruti
Mohan, Viswanathan
Anjana, Ranjit Mohan
Jena, Sidhant
Tandon, Nikhil
Allender, StevenORCID iD for Allender, Steven
Ranjani, Harish
Journal name JMIR research protocols
Volume number 6
Issue number 12
Article ID e242
Start page 1
End page 12
Total pages 12
Publisher JMIR Publications
Place of publication Toronto, Ont.
Publication date 2017-12-12
ISSN 1929-0748
Keyword(s) diabetes mellitus, type 2
Summary BACKGROUND: The prevalence of type 2 diabetes is increasing in epidemic proportions in low- and middle-income countries. There is an urgent need for novel methods to tackle the increasing incidence of diabetes. The ubiquity of mobile phone use and access to Internet makes mobile health (mHealth) technology a viable tool to prevent and manage diabetes. OBJECTIVE: The objective of this randomized controlled trial is to implement and evaluate the feasibility, cost-effectiveness, and sustainability of a reality television-based lifestyle intervention program. This intervention program is delivered via a mobile phone app (mDiab) to approximately 1500 Android smartphone users who are adults at a high risk for type 2 diabetes from three cities in India, namely, Chennai, Bengaluru, and New Delhi. METHODS: The mDiab intervention would be delivered via a mobile phone app along with weekly coach calls for 12 weeks. Each participant will go through a maintenance phase of 6 to 8 months post intervention. Overall, there would be 3 testing time points in the study: baseline, post intervention, and the end of follow-up. The app will enable individuals to track their weight, physical activity, and diet alongside weekly video lessons on type 2 diabetes prevention. RESULTS: The study outcomes are weight loss (primary measure of effectiveness); improvement in cardiometabolic risk factors (ie, waist circumference, blood pressure, glucose, insulin, and lipids); and improvement in physical activity, quality of life, and dietary habits. Sustainability will be assessed through focus group discussions. CONCLUSIONS: If successful, mDiab can be used as a model for translational and implementation research in the use of mHealth technology for diabetes prevention and may be further expanded for the prevention of other noncommunicable diseases such as hypertension and cardiovascular diseases. TRIAL REGISTRATION: Clinical Trials Registry of India CTRI/2015/07/006011 trialid=11841 (Archived by WebCite at
Language eng
DOI 10.2196/resprot.8644
Field of Research 110399 Clinical Sciences not elsewhere classified
HERDC Research category C1 Refereed article in a scholarly journal
Persistent URL

Document type: Journal Article
Collections: School of Health and Social Development
Open Access Checking
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 0 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 5 Abstract Views, 2 File Downloads  -  Detailed Statistics
Created: Mon, 11 Jun 2018, 14:12:33 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact